Navigation

    Forum

    • Register
    • Login
    • Search
    • Categories
    • Recent
    • Popular
    • Users
    • Groups

    NOCc and Guidance on Duration of Clinical Trials

    PAAB Code
    2
    3
    61
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • L
      Lags last edited by

      Hello Jennifer. What are the implications of an NOCc on the use of extension studies in advertising? This refers to the "Guidance Regarding Duration of Clinical Trials Used as Reference Support in Advertising."

      Jennifer Carroll 1 Reply Last reply Reply Quote 0
      • Jennifer Carroll
        Jennifer Carroll @Lags last edited by

        Hello @lags

        In Guidance on Advertising for Drugs with Notice of Compliance with Conditions (Noc/c), point 3 states: “For NOC/c product advertising, studies and/or data which are not presented in the Terms of Market Authorization will not be accepted”. The referenced extension studies guidance would not supersede this restriction.

        L 1 Reply Last reply Reply Quote 0
        • L
          Lags @Jennifer Carroll last edited by

          @jennifer-carroll Thank you.

          1 Reply Last reply Reply Quote 0
          • First post
            Last post